FIELD: pharmaceuticals.
SUBSTANCE: invention relates to new antibacterial depsipeptide compounds and can be used to create agents for the treatment of microbial infections in humans and animals. Also proposed is the use of the said compound for the preparation of an agent having antibacterial activity.
EFFECT: claimed invention expands the range of agents for combating bacterial infection, which can be used in the creation of antibacterial agents.
2 cl, 4 dwg, 1 tbl, 2 ex
R:
or 
| Title | Year | Author | Number |
|---|---|---|---|
| STREPTOMYCES sp. KMM 9044 - PRODUCER OF COMPOUNDS WITH ANTIBACTERIAL ACTIVITY | 2022 |
|
RU2784815C1 |
| GAUSEMYCINS A AND B - GLYCOLIPOPEPTIDE ANTIBACTERIAL ANTIBIOTICS AND METHOD FOR PRODUCTION THEREOF | 2020 |
|
RU2762182C1 |
| METHOD FOR DETERMINING HETERORESISTANT POPULATIONS IN MONOSPECIES CULTURES OF FAST-GROWING BACTERIA | 2021 |
|
RU2774904C1 |
| STRAIN OF ACTINOMYCETE STREPTOMYCES PRATENSIS IS AN ANTIBIOTIC PRODUCER USED TO PROTECT VEGETABLE CROPS FROM SOFT ROT CAUSED BY PHYTOPATHOGENIC PECTOBACTERIUM CARATOVORUM BACTERIA | 2022 |
|
RU2798572C1 |
| STREPTOMYCES BAARNENSIS, A NEW DAPTOMYCIN PRODUCER | 2023 |
|
RU2802575C1 |
| NEW DEPSIPEPTIDES AND METHODS OF THEIR OBTAINMENT | 2002 |
|
RU2348647C2 |
| STRAIN OF STAPHYLOCOCCUS AUREUS CHARACTERIZED BY RESISTANCE TO DAPTOMYCIN AND USED AS A CONTROL TEST CULTURE TO DETERMINE ANTIBIOTIC SENSITIVITY | 2022 |
|
RU2809847C1 |
| MIXED METAL COMPLEXES BASED ON 5-(4-METHYLPHENYL)-2,2'-BIPYRIDINE AND (TETRAFLUOR) SALICYLIC ACIDS, HAVING ANTIBACTERIAL AND FUNGISTATIC ACTIVITY | 2020 |
|
RU2737435C1 |
| METHODS OF TREATING BACTERIAL INFECTIONS | 2014 |
|
RU2666605C2 |
| METHODS OF TREATING TOPICAL MICROBIAL INFECTIONS | 2014 |
|
RU2675360C2 |
